Efficacy and Safety of Rivaroxaban in Acute Non-neoplastic Portal Vein Thrombosis in HCV
Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
Portal vein thrombosis (PVT) in patients with liver cirrhosis may be due to neoplastic growth
or non-neoplastic causes.
- Treating PVT with anticoagulation in liver cirrhosis is difficult to be established but
may be of great benefit in acute symptomatic PVT.
- The ultimate goal is complete recanalization of the portal vein without inducing major
bleeding, abnormal liver function tests or increased mortality.